434 related articles for article (PubMed ID: 19842450)
1. Prevalence of metabolic syndrome among middle aged women in Babol, Iran.
Delavar MA; Lye MS; Khor GL; Hanachi P; Hassan ST
Southeast Asian J Trop Med Public Health; 2009 May; 40(3):612-28. PubMed ID: 19842450
[TBL] [Abstract][Full Text] [Related]
2. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
[TBL] [Abstract][Full Text] [Related]
3. Dietary patterns and the metabolic syndrome in middle aged women, Babol, Iran.
Delavar MA; Lye MS; Khor GL; Hassan ST; Hanachi P
Asia Pac J Clin Nutr; 2009; 18(2):285-92. PubMed ID: 19713190
[TBL] [Abstract][Full Text] [Related]
4. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women.
Esmaillzadeh A; Mirmiran P; Moeini SH; Azizi F
Int J Cardiol; 2006 Apr; 108(3):338-45. PubMed ID: 15963581
[TBL] [Abstract][Full Text] [Related]
5. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome among postmenopausal women in Ecuador.
Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of metabolic syndrome among young adults in Izmir, Turkey.
Soysal A; Demiral Y; Soysal D; Uçku R; Köseoğlu M; Aksakoğlu G
Anadolu Kardiyol Derg; 2005 Sep; 5(3):196-201. PubMed ID: 16140651
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the metabolic syndrome in a Turkish adult population.
Ozsahin AK; Gokcel A; Sezgin N; Akbaba M; Guvener N; Ozisik L; Karademir BM
Diabetes Nutr Metab; 2004 Aug; 17(4):230-4. PubMed ID: 15575344
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome in Saudi Arabia.
Al-Nozha M; Al-Khadra A; Arafah MR; Al-Maatouq MA; Khalil MZ; Khan NB; Al-Mazrou YY; Al-Marzouki K; Al-Harthi SS; Abdullah M; Al-Shahid MS; Al-Mobeireek A; Nouh MS
Saudi Med J; 2005 Dec; 26(12):1918-25. PubMed ID: 16380773
[TBL] [Abstract][Full Text] [Related]
10. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population.
Thomas GN; Ho SY; Janus ED; Lam KS; Hedley AJ; Lam TH;
Diabetes Res Clin Pract; 2005 Mar; 67(3):251-7. PubMed ID: 15713358
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan Healthy Heart Program.
Sarrafzadegan N; Kelishadi R; Baghaei A; Hussein Sadri G; Malekafzali H; Mohammadifard N; Rabiei K; Bahonar A; Sadeghi M; O'Laughlin J
Int J Cardiol; 2008 Dec; 131(1):90-6. PubMed ID: 18190978
[TBL] [Abstract][Full Text] [Related]
12. Association between the metabolic syndrome and its components and gait speed among U.S. adults aged 50 years and older: a cross-sectional analysis.
Okoro CA; Zhong Y; Ford ES; Balluz LS; Strine TW; Mokdad AH
BMC Public Health; 2006 Nov; 6():282. PubMed ID: 17105659
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran.
Mirhosseini NZ; Yusoff NA; Shahar S; Parizadeh SM; Mobarhen MG; Shakery MT
Asia Pac J Clin Nutr; 2009; 18(1):131-6. PubMed ID: 19329406
[TBL] [Abstract][Full Text] [Related]
15. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study.
Nabipour I; Amiri M; Imami SR; Jahfari SM; Shafeiae E; Nosrati A; Iranpour D; Soltanian AR
Int J Cardiol; 2007 May; 118(1):48-53. PubMed ID: 16875744
[TBL] [Abstract][Full Text] [Related]
16. Menopause is an independent predictor of metabolic syndrome in Iranian women.
Eshtiaghi R; Esteghamati A; Nakhjavani M
Maturitas; 2010 Mar; 65(3):262-6. PubMed ID: 19962253
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
18. Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals.
Ishizaka N; Ishizaka Y; Toda E; Hashimoto H; Nagai R; Yamakado M
Hypertens Res; 2005 Jan; 28(1):27-34. PubMed ID: 15969252
[TBL] [Abstract][Full Text] [Related]
19. Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study.
Qader SS; Shakir YA; Nyberg P; Samsioe G
Climacteric; 2008; 11(6):475-82. PubMed ID: 18991074
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
